Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Canner

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Israel Journal of Medical Sciences|May 1, 1983
Aspirin in coronary heart disease. Comparison of six clinical trialsP L Canner
Controlled Clinical Trials|December 1, 1983
Brief description of the Coronary Drug Project and other studiesP L Canner
Statistics in Medicine|April 1, 1987
An overview of six clinical trials of aspirin in coronary heart diseaseP L Canner
Biometrics|December 1, 1977
Monitoring treatment differences in long-term clinical trialsP L Canner
Controlled Clinical Trials|March 1, 1983
Comment on "Statistical inference from clinical trials: choosing the right P value"P L Canner
Controlled Clinical Trials|March 1, 1983
Further comment on "Statistical inference from clinical trials: choosing the right P value"P L Canner
Statistics in Medicine|October 1, 1984
How much data should be collected in a clinical trial? Experience of the coronary drug projectP L Canner
Controlled Clinical Trials|December 1, 1983
The Coronary Drug Project. Monitoring of the data for evidence of adverse or beneficial treatment effectsP L Canner
Controlled Clinical Trials|December 1, 1983
The Coronary Drug Project. Further aspects of data analysisP L Canner
Controlled Clinical Trials|June 1, 1991
Covariate adjustment of treatment effects in clinical trialsP L Canner
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Israel Journal of Medical Sciences|May 1, 1983
Aspirin in coronary heart disease. Comparison of six clinical trialsP L Canner
Controlled Clinical Trials|December 1, 1983
Brief description of the Coronary Drug Project and other studiesP L Canner
Statistics in Medicine|April 1, 1987
An overview of six clinical trials of aspirin in coronary heart diseaseP L Canner
Biometrics|December 1, 1977
Monitoring treatment differences in long-term clinical trialsP L Canner
Controlled Clinical Trials|March 1, 1983
Comment on "Statistical inference from clinical trials: choosing the right P value"P L Canner
Controlled Clinical Trials|March 1, 1983
Further comment on "Statistical inference from clinical trials: choosing the right P value"P L Canner
Statistics in Medicine|October 1, 1984
How much data should be collected in a clinical trial? Experience of the coronary drug projectP L Canner
Controlled Clinical Trials|December 1, 1983
The Coronary Drug Project. Monitoring of the data for evidence of adverse or beneficial treatment effectsP L Canner
Controlled Clinical Trials|December 1, 1983
The Coronary Drug Project. Further aspects of data analysisP L Canner
Controlled Clinical Trials|June 1, 1991
Covariate adjustment of treatment effects in clinical trialsP L Canner
Pageof 3